Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population

J Cutan Med Surg. 2011 Jan-Feb;15(1):37-47. doi: 10.2310/7750.2010.10013.

Abstract

Background: Psoriasis is a common chronic immune-mediated inflammatory disorder of the skin with several associated comorbidities.

Objective: To assess the prevalence of comorbidities in a cohort of psoriasis patients within the Canadian province of Newfoundland and Labrador (NL).

Methods: This cross-sectional observational study investigated hospital-coded comorbidities associated with psoriasis in comparison to the general NL hospitalized population.

Results: Patients died significantly younger than the general population, with patients having an earlier disease onset (≤ 25 years) dying at a younger age than those with a later onset (> 25 years; 59.3 vs 71.2; p = .001). Patients were hospitalized more frequently for several system disorders than the general population, and a potential association was observed between prognostic factors such as age at onset, disease severity, and HLA-Cw6 genotype and certain comorbid conditions.

Conclusion: This study supports an association between psoriasis and other conditions, such as circulatory and endocrine diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cause of Death
  • Comorbidity
  • Cross-Sectional Studies
  • Female
  • Founder Effect*
  • Humans
  • Male
  • Medical Record Linkage
  • Middle Aged
  • Newfoundland and Labrador / epidemiology
  • Prognosis
  • Psoriasis / epidemiology*